FacultyFaculty/Author Profile

Stephen J. Elliott

Sullivan & Cromwell LLP

New York City, NY, USA


Stephen Elliott’s practice focuses on complex commercial litigation in matters involving antitrust, intellectual property, and technology. As a patent litigator, he has focused on pharmaceutical patent infringement actions, primarily in the Hatch-Waxman context. He has also defended infringement claims concerning a variety of other technologies, including computer hardware and software, biotechnology, medical devices, and business methods. In the antitrust area, he has extensive experience in negotiating and defending pharmaceutical patent litigation settlements, and has also defended Robinson-Patman and patent misuse claims. When representing clients on technology, patent, and litigation matters, Mr. Elliott draws on his years of experience as a chemical engineer in the semiconductor and biochemical industries. Mr. Elliott is co-chair of the Technology and Intellectual Property Litigation committee of the Commercial and Federal Litigation Section of the New York State Bar Association.
Stephen J. Elliott is associated with the following items:
Treatise Chapters  Treatise Chapters Antitrust, FTC, and State Competition Law - Pharmaceutical and Biotech Patent Law, Friday, November 17, 2017
Web Segment  Web Segment Recent Developments in Pharmaceutical Patent Antitrust Law - Developments in Pharmaceutical and Biotech Patent Law 2018, Tuesday, October 30, 2018
MP3 Audio  MP3 Audio Recent Developments in Pharmaceutical Patent Antitrust Law - Recent Developments in Pharmaceutical Patent Antitrust Law, Tuesday, October 30, 2018
Transcripts  Transcripts Recent Developments in Pharmaceutical Patent Antitrust Law - Recent Developments in Pharmaceutical Patent Antitrust Law, Tuesday, October 30, 2018
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Recent Developments in Pharmaceutical Patent Antitrust Law - Recent Developments in Pharmaceutical Patent Antitrust Law, Tuesday, October 30, 2018
CHB Chapters  CHB Chapters Actavis and “Reverse-Payment” Settlements of Hatch-Waxman Patent Litigation - Developments in Pharmaceutical and Biotech Patent Law 2018, Wednesday, October 31, 2018
On-Demand Web Programs  On-Demand Web Programs Developments in Pharmaceutical and Biotech Patent Law 2018, Wednesday, November 07, 2018, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.